Argus
•
Oct 14, 2026
INDV: Lowering target price to $34.00
Summary
Indivior Pharmaceuticals Inc has an Investment Rating of HOLD; a target price of $34.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of High; and a Value Subrating
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
LQDA: Raising target price to $43.00
Oct 28, 2026
•
LQDA
ALHC: What does Argus have to say about ALHC?
Oct 28, 2026
•
ALHC
FTRE: Raising target price to $26.00
Oct 28, 2026
•
FTRE
BTSG: Lowering target price to $65.00
Oct 28, 2026
•
BTSG
LQDA: Raising target price to $35.00
Oct 21, 2026
•
LQDA
